Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:January 10, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:January 10, 2023Recruiting
Condition(s):StomatitisLast Updated:April 23, 2013Completed
Condition(s):Sickle Cell Disease; Graft Versus Host DiseaseLast Updated:August 6, 2021Unknown status
Condition(s):Lupus Erythematosus, SystemicLast Updated:August 20, 2019Completed
Condition(s):Kidney TransplantationLast Updated:September 24, 2018Terminated
Condition(s):Benign Paroxysmal Positional VertigoLast Updated:April 3, 2018Completed
Condition(s):Pompe DiseaseLast Updated:April 5, 2022Completed
Condition(s):Transplantation, Homologous; Transplantation, Autologous; Multiple Myeloma; Blood and Marrow Transplant (BMT)Last Updated:October 20, 2017Completed
Condition(s):Mucositis; NeoplasmsLast Updated:February 6, 2019Terminated
Condition(s):AML; MDSLast Updated:December 11, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.